Author:
Cattaneo Dario,Minisci Davide,Baldelli Sara,Mazzali Cristina,Giacomelli Andrea,Milazzo Laura,Meraviglia Paola,Resnati Chiara,Rizzardini Giuliano,Clementi Emilio,Galli Massimo,Gervasoni Cristina
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Infectious Diseases
Reference23 articles.
1. Tenofovir alafenamide: a novel prodrug of tenofovir for the treatment of human immunodeficiency virus;Ray;Antiviral Res.,2016
2. The role of tenofovir alafenamide in future HIV management;Antela;HIV Med.,2016
3. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF);De Clercq;Biochem Pharmacol.,2016
4. The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: meta-analysis;Wang;Medicine (Baltimore),2016
5. Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected adults with renal impairment: 96-Week results from a single-arm, multicenter open-label phase 3 study;Post;J Acquir Immune Defic Syndr.,2016
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献